Cboe UK GBp

Schroders Capital Global Innovation Trust plc - INOV (INOVL.XC)

Compare
9.88 0.00 (0.00%)
At close: November 21 at 4:09 PM GMT
Loading Chart for INOVL.XC
DELL
  • Previous Close 9.88
  • Open 9.88
  • Bid --
  • Ask --
  • Day's Range 9.88 - 9.88
  • 52 Week Range 0.09 - 15.20
  • Volume 200
  • Avg. Volume 2,156
  • Market Cap (intraday) 82.128M
  • Beta (5Y Monthly) 0.55
  • PE Ratio (TTM) --
  • EPS (TTM) -0.05
  • Earnings Date Feb 26, 2025 - Mar 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 19, 2016
  • 1y Target Est --

Schroder UK Public Private Trust plc specializes in investments in startups, midsize, middle market and large stage, early stage and mature stage investments. The fund primarily invests in the healthcare, financials, industrials, technology, consumer goods, telecommunications, basic materials, and biotechnology sector. It seeks to invest in quoted and unquoted companies. It primarily invests in companies incorporated in the United Kingdom or traded on a London Stock Exchange market but can invest in Europe, United States and Asia other countries. The fund seeks to become a significant shareholder in the portfolio companies.

www.schroders.com/en/uk/private-investor/fund-centre/funds-in-focus/investment-trusts/schroders-investment-trusts/uk-public-private-trust/

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: INOVL.XC

View More

Performance Overview: INOVL.XC

Trailing total returns as of 11/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

INOVL.XC
33.47%
FTSE 100
6.79%

1-Year Return

INOVL.XC
33.69%
FTSE 100
10.29%

3-Year Return

INOVL.XC
69.95%
FTSE 100
12.97%

5-Year Return

INOVL.XC
66.16%
FTSE 100
11.66%

Compare To: INOVL.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INOVL.XC

View More

Valuation Measures

Annual
As of 11/25/2024
  • Market Cap

    77.66M

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.46

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -12.04%

  • Return on Equity (ttm)

    -19.41%

  • Revenue (ttm)

    -36.37M

  • Net Income Avi to Common (ttm)

    -38.55M

  • Diluted EPS (ttm)

    -0.05

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.84M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -22.55M

Research Analysis: INOVL.XC

View More

Company Insights: INOVL.XC

Research Reports: INOVL.XC

View More

People Also Watch